Codexis (CDXS) Amortization of Deferred Charges (2024 - 2026)
Codexis (CDXS) recorded quarterly Amortization of Deferred Charges of $376000.0 in Q1 2026, little changed quarter-over-quarter from $376000.0 in Q4 2025, and up 33.81% on a YoY basis from $281000.0 in Q1 2025.
Codexis (CDXS) Amortization of Deferred Charges (2024 - 2026) Analysis & Trends
Codexis' Amortization of Deferred Charges history runs 3 years deep, the most recent figure standing at $376000.0 for Q1 2026.
- In Q1 2026, Amortization of Deferred Charges rose 33.81% year-over-year to $376000.0; the TTM figure through Mar 2026 stood at $1.4 million (up 29.15% YoY), while the FY2025 annual figure was $1.3 million, up 47.46% from the prior year.
- Amortization of Deferred Charges was $376000.0 for Q1 2026 at Codexis, roughly flat from $376000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $376000.0 in Q4 2025 to a low of $82000.0 in Q1 2024.
- Historically, Amortization of Deferred Charges has averaged $285111.1 across 3 years, with a median of $281000.0 in 2025.
- Biggest YoY gain for Amortization of Deferred Charges was 242.68% in 2025; the steepest drop was 10.65% in 2025.
- A 3-year view of Amortization of Deferred Charges shows it stood at $274000.0 in 2024, then jumped by 37.23% to $376000.0 in 2025, then changed by 0.0% to $376000.0 in 2026.
- The last three Amortization of Deferred Charges figures came in at $376000.0 (Q1 2026), $376000.0 (Q4 2025), and $357000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Codexis | 236.00 Mn | 170.86 Mn | 13.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 376,000.00 |
| Mar 31, 2026 | 376,000.00 |
| Dec 31, 2025 | 376,000.00 |
| Dec 31, 2025 | 376,000.00 |
| Sep 30, 2025 | 357,000.00 |
| Sep 30, 2025 | 357,000.00 |
| Jun 30, 2025 | 291,000.00 |
| Jun 30, 2025 | 291,000.00 |
| Mar 31, 2025 | 281,000.00 |
| Mar 31, 2025 | 281,000.00 |
| Dec 31, 2024 | 274,000.00 |
| Dec 31, 2024 | 274,000.00 |
| Sep 30, 2024 | 266,000.00 |
| Sep 30, 2024 | 266,000.00 |
| Jun 30, 2024 | 263,000.00 |
| Jun 30, 2024 | 263,000.00 |
| Mar 31, 2024 | 82,000.00 |
| Mar 31, 2024 | 82,000.00 |